Abstract

The SEP identified priorities to support in future basic and clinical research and pointed out directions likely to result in advances against heart failure. The list is not intended to be all-encompassing and does not address, for example, exciting lines of work already under way. Rather, the recommendations are designed to point out gaps in current knowledge not being adequately addressed and highly promising new directions. Although the incidence of heart failure continues to grow, emerging lines of research provide hope that research advances will eventually lead to more effective treatment and ultimately to prevention. This research will be well served by bringing the latest multidisciplinary approaches and the best investigators to focus on the problems of heart failure. It is hoped the efforts of distinguished expert entities such as the task force and SEP will be a useful guide in addressing the needs of the biomedical community and assisting in its success.

Keywords

MedicineHeart failureLungCardiologyIntensive care medicineInternal medicine

Affiliated Institutions

Related Publications

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

Background Sodium–glucose co‐transporter 2 (SGLT2) inhibitors have been shown to reduce the risk of incident heart failure hospitalization in individuals with type 2 diabetes wh...

2019 European Journal of Heart Failure 430 citations

Publication Info

Year
1997
Type
article
Volume
95
Issue
4
Pages
766-770
Citations
219
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

219
OpenAlex

Cite This

Jay N. Cohn, Michael R. Bristow, Kenneth R. Chien et al. (1997). Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation , 95 (4) , 766-770. https://doi.org/10.1161/01.cir.95.4.766

Identifiers

DOI
10.1161/01.cir.95.4.766